Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer
PPIs may reduce the efficacy of nivolumab, and their use should be carefully considered in patients receiving nivolumab.
Authors
- Masaya Takahashi (ORCID: https://orcid.org/0000-0003-2649-4638)
- Hitomi Nakatsukasa
- Takahiro Toyokawa
- Tomoya Kawaguchi (ORCID: https://orcid.org/0000-0002-7600-4847)
- Yasutaka Nakamura
- Masahito Shibano
- Koichi Taira (ORCID: https://orcid.org/0000-0002-4932-508X)
- Yusuke Ishigami
- Hiroyasu Kaneda (ORCID: https://orcid.org/0000-0002-7696-2391)
Institutions
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1080/1750743x.2025.2491300
- Citations
- 2
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01